News and Comments

ADVENTRIX (ANX): A REVERSE SPLIT WITH SOME EXCITING NEWS.

  Wednesday, April 28, 2010

Despite the emergence of new biological treatments for cancer, Chemotherapy is still essential, and indispensable as a major treatment for malignancies. The adverse events caused by these chemicals were found to be acceptable as a risk versus the great reward of using chemotherapy. The technological evolution that took place in the past decade and the surfacing of state-of-the-art technologies such as nanotechnology, scientists believed possibilities exist now for improving the adverse effect profiles of these therapeutic molecules. Reformulating the existing products has become an increasingly common product lifecycle-management technique. We read that a 2004 report on the U.S. drug market from BCC, Inc. projected that reformulations would grow from 62% of the market in 2003 to 79% in 2008. Finding ways to modify and improve existing products’ side effect profiles has become feasible after being essential but unreachable goal.  More...


Recent Postings


Archive


Tags

Spike Therapeutics (ONCE) SERES THERAPEUTICS (MCRB) Valeant Pharmaceuticals International (VRX) Trastuzumab-DM1 Abbott Laboratories (ABT) Idenix (IDIX) Mirati Therapeutics (MRTX) Global Cell Therapeutics (GBT) ADVENTRIX (ANX) Editas (EDIT) PORTOLA (PTLA) Multiple Myeloma Merck (MRK) Prosensa (RNA) Anadys (ANDS) BIOMARIN (BMRN) Sanofi-Aventis (SAN) Bellicum (BLCM) Zerenex ARGOS (ARGS) SUNESIS PHARMACEUTICALS (SNSS) Velcade (bortezomib) Auspex (ASPX) Genentech Adaptimmune (ADAP) Rapamune Gilead (GILD) CompuGen (CGEN) TOKAI (TKAOI) Sanofi (SNA) ABBVIE (ABBV) Regeneron (REGN) Elan (ELN) Telaprevir AERIE PHARMACEUTICALS Inovio (INO) Jazz Pharmaceuticals (JAZZ) Amgen (AMGN) RenenxBio (RGNX) Intermune (ITMN) Incyte (INCY) Herceptin NEKTAR (NKTR)) REGULUS (RGLS) Bristol-Myers Squibb (BMY) ZALTRAP™ Advaxis (ADXS) Ionis (IONS) Sequenom (SQNM) Ocular Therapeutix (OCUL) Micromet (MITI) Intrexon (XON) Anacor (ANAC) PTC Therapeutics (PTCT) Agenus (AGEN Agenus (AGEN) ACADIA (ACAD) INNOVIVA (INVA) Benlysta (belimumab) GUARDIAN HEALTH Vitae Pharmaceuticals (VTAE) Dendreon (DNDN) Tysabri AGOS (ARGS) Theravance Bio Pharma (TBPH) GlaxoSmithKline (GSK) Seattle Genetics (SGEN) galapagos (GLPG) KITE (KITE) Human Longevity (HLI) Endometrial Cancer CEMPRA (CEMP) KERYX (KERX) Sarepta (SRPT) JUNO (JUNO) Human Genome Sciences (HGSI) Revlimid (lenolidamide) Exelixis (EXEL) Vertex (VRTX) Sanofi (SNY) ISIS (ISIS) ImmunoGen (IMGN) ARCA (ABIO) Ziofpharm (ZIOP) C4 Therapeutics Roche (RHHBY) OncoCyte (OCX) Xoma (XOMA) IDERA (IDRA) Illumina (ILMN) Aimmune Therapeutics (AIMT) Alnylam (ALNY) Cytokinetics (CYTK) Ridaforolimus Dynavax (DVAX) HALOZYME (HALO) MODERNA Ariad (ARIA) Biogen Idec (BIIB) OSI (OSIP) Prolor Biotech (PBTH) Pluristem (PSTI) Alder Biopharmaceuticals (ALDR) VANDA (VNDA) Intercept (ICPT) LEXICON (LXRX) Onyx (ONXX) Galena (GALE) SYNTA (SNTA) Sangamo (SGMO) NANTKWEST (NK) AstraZeneca (AZN) CRISPR Therapeutics (CRSP) Roche (ROCHE) NOVOCURE (NVCR) Theravance (THRX) Array Pharmaceuticals (ARRY) JOUNCE THERAPEUTICS (JNCE) Biocryst (BCRX)